Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP17A1 | P05093 | 1/20 | 0.36 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2605932 | 0.87 | TSHR (0.35) | CYP17A1CYP19A1TSHRNPSR1 | |
| SCHEMBL14411656 | 0.86 | CYP17A1 (0.37) | CYP17A1CYP19A1 | |
| SCHEMBL12446156 | 0.86 | CYP17A1 (0.34) | CYP17A1CYP19A1TSHRNPSR1 | |
| SCHEMBL685197 | 0.84 | CYP19A1 (0.39) | CYP17A1CYP19A1TSHRNPSR1 | |
| SCHEMBL686054 | 0.84 | CYP19A1 (0.39) | CYP17A1CYP19A1TSHRNPSR1 | |
| SCHEMBL2606037 | 0.84 | CYP17A1 (0.31) | CYP17A1CYP19A1TSHRNPSR1 | |
| SCHEMBL2606034 | 0.84 | CYP17A1 (0.31) | CYP17A1CYP19A1TSHRNPSR1 | |
| SCHEMBL685199 | 0.82 | CYP17A1 (0.38) | CYP17A1CYP19A1TSHRNPSR1 | |
| SCHEMBL4410081 | 0.82 | CYP17A1 (0.30) | CYP17A1CYP19A1 | |
| SCHEMBL12345922 | 0.81 | CYP19A1 (0.41) | CYP17A1CYP19A1TSHRNPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100316951-A1 | SALT AND PHOTORESIST COMPOSITION CONTAINING THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-12-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100316951-A1 | SALT AND PHOTORESIST COMPOSITION CONTAINING THE SAME | THEM6, INTS6, CRY1 | CYP17A1 3113/4885CYP19A1 4077/4885TSHR 528/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.